Series A Therapeutics Companies

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.

RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).

Ciba Health offers a personalized digital therapeutics and virtual care platform.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).

HOGUGU is a therapist booking platform that offers treatment checks and screening with online reservations and card payment facilities.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Forta is a provider of healthcare services to help children with autism.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Automera focuses on a novel therapeutic methods to develop drugs.

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Mable Therapy provides online speech & language therapy and counseling for children using purpose-built technology.

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

InHandPlus is developing solutions to improve the way we take our prescribed medications.

Mentavi is an online medication management platform that provides access to quality attention deficit hyperactivity disorder assessments.

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.